Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で31.96%の成長率を示しています。
成長中
同社は成長フェーズにあり、最新の年間収益はUSD 18.79Mに達しています。
割高
同社の最新のPEは46.57で、過去3年間の水準と比較して高値圏にあります。
機関投資家の買い増し
最新の機関投資家の保有株数は5.53M株で、前四半期比で6.00%増加しています。
ジェームズ・シモンズが保有
スター投資家ジェームズ・シモンズは本銘柄を0.00株保有しています。
市場活動が低調
同社への投資家の関心は低下しており、20日間の売買回転率は-0.65です。